Business Services

Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in Ireland to founding a major commercial stage pharma firm...

What motivated you to originally consider and pursue a career in the pharma?

Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, which paint a promising picture for patients with such conditions.

Disabling hearing loss and other inner ear disorders affect more than 360 million people worldwide, with approximately one billion additional people at risk, according to the World Health Organization. Hearing loss is triggered by many factors, with ageing and noise exposure being two of the most common causes.

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI and big data are set to galvanise the industry.

Even if you haven’t been paying attention, it is hard to miss the buzz around artificial intelligence or deep learning and how the technology is only steps away from changing lives forever. The optimism is especially significant in the pharmaceutical and healthcare industry as researchers continue to look out for cures for complex diseases.

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout her teens, Niamh ni Ruari now uses a wheelchair for mobility. She shares her story of life with her condition and a few thoughts on society’s attitudes towards the disabled community.

Can you tell me a bit about the condition, your diagnosis and the symptoms you experience?

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done to improve the way in which we treat medical as well as societal problems related to these conditions.

Mental health issues have been estimated to cost the world economy $2.5 trillion each year. To put that into perspective, the United Kingdom’s gross domestic product (GDP) was $2.6 trillion in 2017. Meanwhile, the world’s economy was estimated to be worth just $78.28 trillion in 2014.